Adheris Health Limited (ASX: AHE) is a global healthcare technology company headquartered in Woburn, Massachusetts, and listed on the Australian Securities Exchange. Formerly known as MedAdvisor Limited, the company underwent a significant rebranding in December 2025 to better represent its specialized focus on pharmacy-driven patient engagement solutions. The entity operates as a leader in the digital health space, providing sophisticated tools that connect patients, pharmacists, and pharmaceutical manufacturers across key markets in Australia, the United States, and the United Kingdom.
The company’s core operations are powered by THRiV, an AI-enabled, omni-channel platform that facilitates personalized patient experiences and improves pharmacy workflows. Adheris Health manages an extensive network of assets and partnerships, including collaborations with more than 34,000 pharmacies in the United States alone. This vast operational footprint allows the company to reach over two-thirds of the U.S. population, offering services that range from medication reminders and educational content to complex adherence programs designed to optimize health outcomes.
Strategically, Adheris Health is positioned as a critical link in the medication supply chain, focusing on high-growth therapeutic areas such as diabetes, immunology, and chronic disease management. The company’s value proposition lies in its ability to leverage data-driven insights to reduce medication non-adherence, which is a major cost driver in global healthcare. By transitioning toward a more scalable, technology-first model and reducing its reliance on seasonal vaccine revenue, the company aims to deliver sustainable growth and enhanced value to its pharmaceutical and retail pharmacy partners.
© 2026 StockWire X Pty Ltd. All rights reserved.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
